Patents by Inventor Inseon Song

Inseon Song has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200360332
    Abstract: Compound, stereoisomers, enantiomers or diastereomers thereof, physiologically acceptable salts thereof, mixtures of said compound for use in increasing mental capability, and a pharmaceutical composition. The increasing of mental capability is tested in learning experiments with Drosophila melanogaster larvae or older animals, which are raised with standard feed mash or with different concentrations of FSE-20 in the feed mash. In the learning experiment, the animals are each subjected to one of two inverse training regimens and then subjected to a test. In the training, a first scent was presented with the feed reward to the first group, while a second scent was presented alone to the first group. The second group was trained inversely. In the test of the learning experiment, it was subsequently examined whether the larvae of both groups prefer the first scent or the second scent in a selection situation; thus, their learning and memory capability was determined.
    Type: Application
    Filed: November 23, 2018
    Publication date: November 19, 2020
    Inventors: Birgit Michels, Bertram Gerber, Ludger Wessjohann, Katrin Franke, Stephan Sigrist, Anuradha Bhukel, Oleh Lushchak, Hanna Zwaka, Ruth Bartels, Alexander Dityatev, Inseon Song, Markus Fendt, Volkmar Lessmann, Thomas Endres, Thilo Kaehne
  • Patent number: 7626076
    Abstract: The disclosure concerns a method for resistance of epilepsy by suppressing the function of alpha 1G protein of T-type calcium channels, use of suppressor of alpha 1G protein for prevention or treatment for epilepsy, knockout mice resisting epilepsy by disrupting alpha 1G subunit of T-type calcium channel, and preparation method thereof. The ?1G-knockout transgenic mouse can be used for investigating the relationship between diseases particularly neuropathy or psychopathy and the function of ?1G T-type calcium channel via various behavioral tests since ?1G subunit is mainly expression in central nervous system (CNS) and pheripheral nervous system (PNS). Further, the ?1G-knockout transgenic mouse can be used for screening antileptic agents.
    Type: Grant
    Filed: November 23, 2007
    Date of Patent: December 1, 2009
    Assignee: Orient Bio., Inc.
    Inventors: Hee-Sup Shin, Daesoo Kim, Sehoon Keum, Inseon Song
  • Publication number: 20080201787
    Abstract: The disclosure concerns a method for resistance of epilepsy by suppressing the function of alpha 1G protein of T-type calcium channels, use of suppressor of alpha 1G protein for prevention or treatment for epilepsy, knockout mice resisting epilepsy by disrupting alpha 1G subunit of T-type calcium channel, and preparation method thereof. The ?1G-knockout transgenic mouse can be used for investigating the relationship between diseases particularly neuropathy or psychopathy and the function of ?1G T-type calcium channel via various behavioral tests since ?1G subunit is mainly expression in central nervous system (CNS) and pheripheral nervous system (PNS). Further, the ?1G-knockout transgenic mouse can be used for screening antileptic agents.
    Type: Application
    Filed: November 23, 2007
    Publication date: August 21, 2008
    Inventors: Hee-Sup Shin, Daesoo Kim, Sehoon Keum, Inseon Song
  • Publication number: 20060025397
    Abstract: The disclosure concerns a method for resistance of epilepsy by suppressing the function of alpha 1 G protein of T-type calcium channels, use of suppressor of alpha 1 G protein for prevention or treatment for epilepsy, knockout mice resisting epilepsy by disrupting alpha 1 G subunit of T-type calcium channel, and preparation method thereof. In addition, suppressing alpha 1 G protein of T-type calcium channels does not occur epilepsy, and alpha 1 G-deficient mice are useful to study of mechanism related to epilepsy.
    Type: Application
    Filed: January 18, 2002
    Publication date: February 2, 2006
    Inventors: Hee-Sup Shin, Daesoo Kim, Sehoon Keum, Inseon Song